StockData

Alphatec vs Globus Medical

ATEC and GMED side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ATEC and GMED compare

Globus Medical is the larger company, worth 9.0 times as much as Alphatec ($9.5B against $1.1B).

Globus Medical grew revenue faster over the last twelve months (19.7% versus 15.3% for Alphatec).

Globus Medical keeps more of each dollar of sales as profit, with a net margin of 17.0% compared with −10.3% at Alphatec.

Globus Medical scores higher on the StockData Score (22 against 7 for Alphatec), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricATECGMED
Size and price
Market cap$1.1B$9.5B
Share price$6.78$70.50
Change, 1 year−66.4%−16.1%
Change, 5 years−35.9%10.2%
Beta (5Y)0.670.72
Employees9136,000
StockData Score
Total score722 (better)
Valuation score16 (better)
Growth score35 (better)
Performance score25 (better)
Health score16 (better)
Dividend score00
Valuation
P/E–18.0×
P/S1.3× (better)3.0×
P/B–2.0×
EV/EBITDA38.9×9.6× (better)
P/FCF343×12.5× (better)
PEG–0.63
FCF yield0.29%8.0% (better)
Fair value–$126.13
Margin of safety–44.1%
Growth
Revenue growth (TTM)15.3%19.7% (better)
Revenue growth, 5Y average39.5% (better)30.1%
Net income growth (TTM)–50.1%
EPS growth (TTM)–50.4%
EPS growth, 5Y average–31.2%
Profitability
Gross margin71.3% (better)68.5%
Operating margin−3.6%20.3% (better)
Net margin−10.3%17.0% (better)
FCF margin0.37%24.0% (better)
Return on equity−1888%11.8% (better)
Return on invested capital−5.0%12.6% (better)
Financial health
Debt / equity–0.00
Net debt / EBITDA12.06–
Interest coverage−0.7×–
Current ratio2.364.62 (better)
Altman Z-score−0.539.62 (better)
Piotroski F-score69 (better)
Dividends and buybacks
Buyback yield–2.3%
Shareholder yield0.00%2.3% (better)
Ownership
Held by institutions72.7%88.9%
Held by insiders23.5%17.8%
Insider net buying, 12 months−$40.9M−$15.3M (better)
Superinvestors holding–1
Short interest, % of float12.0%8.6%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.